| Up
2006P-0399:
To Determine Whether PhosLo (calcium acetate) Tablets, eq 169 mg
Calcium, and PhosLo (calcuim acetate) Capsules, eq 169 mg Calcium,
has been Withdrawn for Safety or Efficacy Reasons
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
| |
ACK1 |
|
09/28/2006
|
|
09/28/2006
|
|
Federal Government |
|
FDA/DDM to Beckloff
Associates |
|
|
|
|
|
|
|
pdf |
|
|
|
| |
|
|
Signature: |
|
Jennie C. Butler
|
|
| |
| |
CP1 |
|
09/28/2006
|
|
09/28/2006
|
|
Association
|
|
Beckloff Associates
|
|
|
|
|
|
|
|
pdf |
|
|
|
| |
Signature: |
|
Miguel A. de Soto-Perera,
Ph.D. |
|
Top | Up
Page last updated
October 19, 2006
kk
Dockets Home Page | Dockets
Contacts and Location | Operating
Status | Item
Code Definitions | Federal
Register
FDA Home Page | Search
FDA Site | FDA A-Z Index
| Contact FDA
FDA/Dockets Management |
